Skip to main content
main-content

Zeitschrift

The European Journal of Health Economics

The European Journal of Health Economics 1/2018

Ausgabe 1/2018

Inhaltsverzeichnis ( 12 Artikel )

09.10.2017 | Editorial | Ausgabe 1/2018

Competition in pharmaceuticals: more product- than price-oriented?

Livio Garattini, Anna Padula

03.01.2017 | Original Paper | Ausgabe 1/2018 Open Access

Competition and quality indicators in the health care sector: empirical evidence from the Dutch hospital sector

R. R. Croes, Y. J. F. M. Krabbe-Alkemade, M. C. Mikkers

16.01.2017 | Original Paper | Ausgabe 1/2018 Open Access

A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK

Evelina A. Zimovetz, Alain Joseph, Rajeev Ayyagari, Josephine A. Mauskopf

22.12.2016 | Original Paper | Ausgabe 1/2018

Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy

Umberto Restelli, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, Davide Croce

07.01.2017 | Original Paper | Ausgabe 1/2018 Open Access

Investigating social inequalities in older adults’ dentition and the role of dental service use in 14 European countries

Jing Shen, Stefan Listl

13.01.2017 | Original Paper | Ausgabe 1/2018 Open Access

Good jobs, good pay, better health? The effects of job quality on health among older European workers

Golo Henseke

09.02.2017 | Original Paper | Ausgabe 1/2018 Open Access

A methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based economic evaluations

Felix Achana, Stavros Petrou, Kamran Khan, Amadou Gaye, Neena Modi, On behalf of Medicines for Neonates Investigators

03.02.2017 | Original Paper | Ausgabe 1/2018

Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial

Bernhard Michalowsky, Steffen Flessa, Tilly Eichler, Johannes Hertel, Adina Dreier, Ina Zwingmann, Diana Wucherer, Henriette Rau, Jochen René Thyrian, Wolfgang Hoffmann

31.01.2017 | Original Paper | Ausgabe 1/2018

A “healthy immigrant effect” or a “sick immigrant effect”? Selection and policies matter

Amelie F. Constant, Teresa García-Muñoz, Shoshana Neuman, Tzahi Neuman

16.03.2017 | Original Paper | Ausgabe 1/2018 Open Access

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

Aris Angelis, Ansgar Lange, Panos Kanavos

14.02.2017 | Original Paper | Ausgabe 1/2018

Corruption costs lives: evidence from a cross-country study

Qiang Li, Lian An, Jing Xu, Mina Baliamoune-Lutz

30.06.2017 | Current Opinion | Ausgabe 1/2018

Patient preferences: a Trojan horse for evidence-based medicine?

Afschin Gandjour

Aktuelle Ausgaben